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Abstract
Background: Recent work has shown that population stratification can have confounding effects
on genetic association studies and statistical methods have been developed to correct for these
effects. Subsets of markers that are highly-differentiated between populations, ancestry-informative
markers (AIMs), have been used to correct for population stratification. Often AIMs are discovered
in one set of populations and then employed in a different set of populations. The underlying
assumption in these cases is that the population under study has the same substructure as the
population in which the AIMs were discovered. The present study assesses this assumption and
evaluates the portability between worldwide populations of 10 SNPs found to be highly-
differentiated within Britain (BritAIMs).
Methods: We genotyped 10 BritAIMs in ~1000 individuals from 53 populations worldwide. We
assessed the degree to which these 10 BritAIMs capture population stratification in other groups
of populations by use of the Fst statistic. We used Fst values from 2750 random markers typed in
the same set of individuals as an empirical distribution to which the Fst values of the 10 BritAIMs
were compared.
Results:  Allele frequency differences between continental groups for the BritAIMs are not
unusually high. This is also the case for comparisons within continental groups distantly related to
Britain. However, two BritAIMs show high Fst between European populations and two BritAIMs
show high Fst between populations from the Middle East. Overall the median Fst across all
BritAIMs is not unusually high compared to the empirical distribution.
Conclusion: We find that BritAIMs are generally not useful to distinguish between continental
groups or within continental groups distantly related to Britain. Moreover, our analyses suggest
that the portability of AIMs across geographical scales (e.g. between Europe and Britain) can be
limited and should therefore be taken into consideration in the design and interpretation of genetic
association studies.
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Background
Whole-genome association studies (GWASs) have proven
extraordinarily successful in mapping loci that associate
with common complex human diseases [for reviews see
[1,2]]. Whereas candidate gene and linkage analyses have
identified a few dozen replicable associations between
genetic markers and complex diseases [3], GWASs have
provided compelling evidence for more than 150 gene-
disease associations since their introduction in 2006 [1].
The presence of population stratification has presented
one of the main statistical challenges in GWASs. Popula-
tion stratification refers to differences in allele frequencies
between cases and controls related to ancestry rather than
disease status. Long before technologies for GWASs were
available, it was recognized that differences in ancestry
between cases and controls can present a substantial con-
founding effect in case-control studies [4]. This is espe-
cially true in cases where disease risk differs between
groups with different ancestry. For example, prostate can-
cer is more frequent in individuals of African ancestry
compared to individuals of European ancestry [5], and
previous significant genetic associations with prostate
cancer become nonsignificant when correcting for these
differences in ancestry [6]. The presence of population
stratification can inflate false positive rates or cause
reduced power and it has become standard practice to
evaluate and correct for genetic ancestry in GWASs [for a
review see [7]].
Currently there are two widely-used approaches for cor-
recting for population stratification in GWASs: structured
association (SA) [8] and principal components analysis
(PCA) [9]. SA uses the program STRUCTURE [10] to esti-
mate the number of sub-populations, k, and then for each
individual assigns a probability of membership to each of
k subpopulations. It is then tested whether allele frequen-
cies are dependent on phenotype within each k subpopu-
lation. PCA reduces high-dimensional data to a small
number of dimensions and uses the axes of variation, or
eigenvectors, from these dimensions to calculate ancestry-
adjusted genotypes and phenotypes. Both of these meth-
ods rely on inferences of ancestry from genome-wide SNP
data. It has been shown that accurate estimates of individ-
ual ancestry can be obtained from a subset of SNPs from
genome-wide data and these are referred to as ancestry-
informative markers (AIMS) [for a review see [7]]. AIMs
are characterized by substantially different allele frequen-
cies between populations and can be used to estimate the
proportion of an individual's ancestry that is derived from
these populations. Before running GWAS, AIMs can be
used to match cases and controls, and outlier individuals
whose ancestry is not typical of the population under
study can be excluded [11]. The main intention for the
development of sets of AIMs, however, is to provide a set
of markers that effectively control for population stratifi-
cation in association studies in which samples have not
been typed with genome-wide SNP arrays. These sets of
AIMs are designed to capture all of the necessary ancestry
information required to correct for stratification in candi-
date gene studies, in replication studies of GWASs, or in
fine-mapping studies that focus on specific genomic
regions identified from GWASs.
Sets of AIMs have been developed to distinguish among
continental groups [12-16]. These sets of AIMs will be use-
ful in controlling for stratification in admixed popula-
tions especially when mapping traits that are known to
differ by continental ancestry, for example skin pigmenta-
tion [17]. Most GWASs, however, have focused on sam-
ples of European ancestry and population stratification
within Europe has therefore been assessed in detail [e.g.
[18-20]]. From several genome-wide SNP data sets, sets of
European AIMs have been developed [21-25] that distin-
guish stratification primarily along north-south and east-
west gradients.
While European AIMs will be useful in studies that exam-
ine individuals of diverse European origin, many GWASs
focus on cohorts of much more homogeneous ancestry
(e.g. individuals from within a single country). It has been
shown that even moderate levels of population stratifica-
tion in relatively homogeneous populations can con-
found results in well-designed case-control studies
[26,27]. For example, spurious associations due to popu-
lation stratification can arise if samples are drawn from
two different cities within a country [e.g. Dresden and
Munich in Germany; [18]] and can even appear in genetic
isolates like the Icelandic [28] and Finnish populations
[29]. Despite these warnings, association studies that do
not properly correct for population structure continue to
be published [e.g. [30]].
Studies that do incorporate a correction for the confound-
ing effects of population structure are to be commended.
However, the correction for population structure is only
as good as the markers chosen for the correction. In gen-
eral, the precondition for the use of a set of AIMs is that
the population under study has the same substructure as
the population in which the AIMs were discovered. In sev-
eral recent association studies, this precondition has been
left unevaluated and potentially uninformative AIMs have
been used to correct for population stratification. For
example, Sulem et al. [31] tested for the presence of pop-
ulation stratification in Iceland with a set of AIMs that dis-
tinguish between European populations [24]. To correct
for population stratification in association studies in
Asian populations, SNPs with high Fst between Asians
and other continental groups have been employed
[32,33]. Similarly, correcting for population structure in
Caucasians, Hu et al. [34] use 38 SNPs that are highly dif-BMC Medical Genomics 2009, 2:45 http://www.biomedcentral.com/1755-8794/2/45
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ferentiated between continental groups. These studies
demonstrate that the underlying assumption that AIMs
are largely portable across geographical scales is pervasive.
To assess the portability of AIMs between populations and
across geographic scales, we genotyped 10 SNPs found to
be highly-differentiated within Britain (BritAIMs) in
~1000 individuals from 53 populations worldwide.
Although these 10 BritAIMs do not constitute a complete
set of AIMs that fully capture population structure within
Britain, they are nevertheless useful for evaluating the
portability of AIMs across geographic scales. We evaluated
the usefulness of these BritAIMs as AIMs between and
within different continents by comparing Fst values for
the BritAIMs to Fst values from 2750 random markers
typed in the same set of worldwide samples. Our results
suggest that AIMs have limited portability between
human populations and that caution is warranted in the
use of AIMs discovered in a population whose substruc-
ture does not match the population in which they are
being employed.
Methods
We selected 13 SNPs identified as "highly-differentiated"
within Britain from a data set of ~500,000 SNPs typed in
~16,000 British individuals [see Table 1; [35]]. These
highly-differentiated SNPs had the lowest P values from a
χ2 test of allele frequency difference between 12 geo-
graphic regions of Britain defined by postcode. We geno-
typed these 13 SNPs in the CEPH-HGDP Panel [36]. The
CEPH-HGDP panel includes 952 individuals from 53
populations after the removal of atypical and related indi-
viduals [37]. Genotypes were generated by KBioscience
using a competitive allele-specific PCR SNP genotyping
system [38]. Cluster plots were analysed visually and the
following 3 SNPs were removed. SNP rs6644913 was
removed because it maps to the X chromosome; we
restricted our analyses to the autosomes because Fst values
from the sex chromosomes are not comparable to auto-
somal Fst values. SNP rs3873375 was removed because it
maps to multiple genomic regions and shows 4 distinct
genotype clusters. Finally, the genotyping of SNP
rs1042712 failed completely. As independent verification
of the 10 remaining SNPs, our genotype data were com-
pared to genotypes generated from 67 individuals of
diverse ancestry from the CEPH-HGDP panel in the labo-
ratory of MS using the Affymetrix GeneChip 500K Map-
ping Array Set (unpublished data). One SNP, rs12797951,
showed substantial discordance between our genotypes
and the genotypes from the Affymetrix platform (data not
shown). We therefore retrieved genotype data for this SNP
from the ~650,000 SNPs typed in the CEPH-HGDP using
Illumina HumanHap650K Beadchips [39]. The Illumina
and Affy data were consistent for rs12797951 and we
therefore used the data from Li et al. [39] for SNP
rs12797951. The final set of 10 SNPs are the British ances-
try-informative markers (BritAIMs) presented in Table 1.
Genotype calls were made by visual inspection. None of
the 10 SNPs were out of Hardy-Weinberg equilibrium
after Bonferroni correction for multiple comparisons (53
populations × 10 SNPs = 530 comparisons). In the 7 cases
of significant (P < 0.05 without Bonferroni correction)
deviation from Hardy-Weinberg expectations for a SNP in
a population, cluster plots were re-evaluated and no data
were removed. The amount of missing data per SNP
ranged from 0% – 6.5% with a mean of 3.1%. These data
are accessible by request to the corresponding author or
from the CEPH database [40].
Fst was calculated according to equation 10 in Weir and
Cockerham [41]. Negative Fst values were set to 0. "Global
Fst" for each of the 10 SNPs was calculated as the degree
of differentiation among the 7 geographic regions repre-
sented in the CEPH-HGDP panel. Results remain
unchanged when global Fst was calculated as the differen-
tiation among all 53 populations rather than the 7
regions. We compared our observed Fst values for the 10
Table 1: Fst values of the 10 BritAIMs and the associated P values.
Global Europe Middle East Africa Central South Asia East Asia Oceania America
BritAIMs Fst P Fst P Fst P Fst P Fst P Fst P Fst P Fst P
rs7696175 0.074 0.551 0.129 0.000 0.002 0.840 0.052 0.469 0.011 0.748 0.018 0.802 0.067 0.439 0.118 0.333
rs1460133 0.035 0.842 0.062 0.043 0.027 0.286 0 1 0.022 0.502 0.010 0.916 NA NA 0.042 0.695
rs9378805 0.115 0.321 0.030 0.280 0.043 0.136 0.019 0.796 0.020 0.554 0.016 0.831 0.072 0.424 0.027 0.754
rs11790408 0.067 0.594 0.043 0.141 0.088 0.022 0.028 0.714 0.046 0.169 0.009 0.920 0.015 0.709 0.108 0.370
rs12295525 0.068 0.591 0.034 0.226 0.008 0.666 0.047 0.513 0.024 0.454 0.017 0.809 NA NA 0.021 0.820
rs12797951 0.106 0.365 0 1 0.105 0.015 0.037 0.611 0.053 0.116 0.061 0.136 NA NA 0.175 0.167
r s 1 0 7 7 4 2 4 1 0 . 1 0 3 0 . 3 8 3 0101 0 . 0 9 0 0 . 2 2 6 0 . 0 2 4 0 . 4 7 0 0 . 0 2 9 0 . 5 8 0 0 . 0 0 4 0 . 7 6 0 0 . 1 3 9 0 . 2 4 7
rs17449560 0.036 0.835 0.017 0.520 0.043 0.135 0.112 0.146 0.003 0.909 0.017 0.814 0.199 0.210 0.061 0.581
rs3760843 0.033 0.855 0.024 0.369 0 1 0.073 0.320 0.014 0.665 0.021 0.747 0.144 0.295 0.139 0.247
rs2143877 0.078 0.529 0.046 0.117 0.011 0.585 0.053 0.460 0.004 0.892 0.015 0.857 0.005 0.754 0.038 0.714
Global Fst was calculated among the 7 continental regions listed as column titles. P values were generated by comparison to an empirical 
distribution of 2750 markers (see Methods). Significant P values (P < 0.05) are in bold.BMC Medical Genomics 2009, 2:45 http://www.biomedcentral.com/1755-8794/2/45
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BritAIMs to an empirical Fst distribution from 2750 auto-
somal markers (2540 SNPs [42] and 210 indels [43])
typed in 927 individuals from the CEPH-HGDP panel. In
cases where the same allele was fixed in all populations
being compared, the SNP was considered non-informa-
tive and no Fst value was assigned. This resulted in differ-
ent numbers of observations for the different empirical
distributions with a minimum 2286 SNPs making up the
empirical Fst distribution within Oceania. To allow for an
unbiased comparison to the empirical distribution, Fst for
the 10 BritAIMs was calculated from the same set of 927
individuals from which the empirical Fst distribution was
calculated. For each BritAIM, a P value was calculated as
the proportion of Fst values from the empirical distribu-
tion that were ≥ the observed Fst value. We use P < 0.05 as
our threshold for "significance". It should be noted that
"significant" therefore describes a value only in relation to
the empirical distribution.
Results
To assess the portability of AIMs, we used the Fst statistic
[44] to measure the degree of genetic differentiation
within and between continental groups of ten BritAIMs,
i.e. SNPs identified as "highly-differentiated" within Brit-
ain [35]. Fst is a commonly employed and useful measure
of allele frequency difference between populations and
takes on values ranging from 0 (no difference) to 1 (fixed
difference). SNPs with high Fst values are highly differen-
tiated between populations and are therefore informative
about population structure and are useful as AIMs [e.g.
[23,45]]. The list of 10 BritAIMS is presented in Table 1
along with Fst values and associated P  values for the
among-continent (i.e. global) and within-continent com-
parisons.
We first tested whether the 10 BritAIMs were highly differ-
entiated among the 7 continental groups of the CEPH-
HGDP panel by comparing global Fst values of the Brit-
AIMs to the empirical distribution of global Fst values
from 2750 random markers. None of the 10 BritAIMs
have significantly high global Fst values (Figure 1, Table
1). We assessed population differentiation on a finer geo-
graphical scale by calculating Fst within continents. The P
values for each of these comparisons are presented in
Table 1. Only 4 BritAIMs showed significantly high Fst
values (P < 0.05) in the within-continent analyses and
these are highlighted in bold in Table 1: two BritAIMs
(rs7696175, rs1460133) showed significantly high Fst
within Europe and two were significant within the Middle
East (rs11790408, rs12797951). Figure 2 displays the
positions of the BritAIMs in the empirical Fst distributions
of Europe and the Middle East.
To test whether BritAIMs are highly differentiated as a
group, we compared the median Fst of the 10 BritAIMs to
a distribution of median Fst values from 10 SNPs sampled
at random 10,000 times from the empirical distribution.
This allows an assessment of how differentiated the 10
BritAIMs are compared to the expectation at random. At
the worldwide scale, the median global Fst of the 10 Brit-
AIMs does not differ significantly from the expectation
generated from 10,000 random samples (Fst = 0.071, P =
0.692). However, the comparisons within each continen-
tal group revealed that the median Fst of the BritAIMs is
significantly high within Europe (median Fst = 0.0316, P
= 0.039; Table 2).
Fst calculations within a continent summarize the degree
of allele frequency differentiation among all populations
within a continent and can be driven to high values by sin-
gle outlier populations. Therefore, we investigated the
four BritAIMs with significantly high Fst values in more
detail by calculating Fst for each pairwise comparison
between populations within a continent. Figure 3 shows
how these population pairwise Fst values compare to the
corresponding Fst values from the empirical distribution.
Finally, Figure 4 provides a view of worldwide allele fre-
quencies and population differentiation for rs7696175,
the most highly-differentiated BritAIM within Europe.
Similar plots of worldwide allele frequencies and popula-
tion differentiation are provided for each BritAIM in Addi-
tional File 1.
Discussion
The presence of population stratification is a potential
source of false positives, and thus of spurious associa-
tions, in disease association studies. Recently, a number of
Global Fst distribution for 2750 random markers Figure 1
Global Fst distribution for 2750 random markers. The 
global Fst values of the 10 BritAIMs are indicated by vertical 
lines.
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studies have identified AIMs and have recommended their
use to control for population stratification in association
studies [12,13,21,22,25]. The sets of AIMs identified to
date show large allele frequency differences either
between continental groups (e.g. Africans and Europeans)
or between populations within a continent (e.g. Europe).
However, many association studies are conducted in rela-
tively homogeneous populations. The medical genetics
literature provides numerous examples where AIMs dis-
covered at one geographic scale are used to correct for
population stratification at finer geographic scales [e.g.
[31-34]]. It remains unclear, however, whether AIMs iden-
tified as informative within Europe, for example, will also
prove useful at finer geographical scales (e.g. within Brit-
Fst values of the 2750 random markers within Europe (A) and within the Middle East (B) Figure 2
Fst values of the 2750 random markers within Europe (A) and within the Middle East (B). The Fst values of the 10 
BritAIMs are indicated by vertical lines. BritAIMs that lie within the top 5% of the empirical distribution are highlighted with 
asterisks.
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Table 2: Median Fst of the 10 BritAIMs within each continent and 
the associated P values
Continental Group Median Fst P value
Europe 0.0316 0.039
Central South Asia 0.021 0.574
Africa 0.0492 0.49
Middle East 0.01895 0.302
East Asia 0.017 0.992
America 0.08465 0.414
Oceania 0.067 0.362
P values generated by random sampling from the empirical 
distribution (see Methods). Significant P values (P < 0.05) are in bold.BMC Medical Genomics 2009, 2:45 http://www.biomedcentral.com/1755-8794/2/45
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Levels of population differentiation for 2 BritAIMs with significantly high Fst within Europe (A) and 2 BritAIMs with significantly  high Fst within the Middle East (B) Figure 3
Levels of population differentiation for 2 BritAIMs with significantly high Fst within Europe (A) and 2 BritAIMs 
with significantly high Fst within the Middle East (B). Each box in each matrix represents a population pairwise Fst 
comparison. The shaded boxes in the matrices show which pairwise Fst values are significant compared to the empirical distri-
bution at three P value thresholds (see the P value legend).
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ain). The present study takes a first step in addressing this
issue by examining the portability of AIMs between pop-
ulations and across geographic scales.
The 10 SNPs identified as highly-differentiated within
Britain (BritAIMs) are not highly differentiated on a
worldwide scale: none of the global Fst values for the Brit-
AIMs lie in the upper tail of the empirical global Fst distri-
bution (Figure 1). The median global Fst of the 10
BritAIMs is also not unusually high compared to the
expectation at random (P = 0.692). Thus, AIMs identified
at a fine geographic scale (i.e. within Britain) are not
informative on a worldwide scale. This result was foresee-
able since there is no a priori reason for expecting SNPs
that differ dramatically in allele frequency within Britain
to differ dramatically among continental groups.
Within continents, only 4 of the 10 BritAIMs have signifi-
cantly high Fst values (Figure 2). These 4 BritAIMs are
found within the top 5% of the empirical distributions
from Europe and the Middle East. These two continental
groups are assumed to be more closely related to Britons
than the other continental groups included in the present
study, and this result therefore suggests that some AIMs
may be portable within a restricted geographic range.
When the patterns of population differentiation for these
4 BritAIMs are examined in more detail, it is clear that the
signal from rs1460133 is derived almost exclusively from
the Basque who differ significantly from most of the other
European populations for this SNP (Figure 3). Thus, while
rs1460133 may be an informative marker for Basque
ancestry, it does not show the dramatic gradient of allele
frequency across the continent that is characteristic of
Worldwide allele frequencies and population differentiation for rs7696175, the most highly differentiated BritAIM within  Europe Figure 4
Worldwide allele frequencies and population differentiation for rs7696175, the most highly differentiated Brit-
AIM within Europe. The vertical bar chart displays the minor allele frequency in each of the populations represented in the 
CEPH-HGDP panel with sample sizes (number of individuals) on the left. The shaded boxes in the 53 × 53 and 7 × 7 matrices 
show which pairwise Fst values are significant compared to the empirical distribution at three P value thresholds (see the 
boxed-in P value legend) for the population by population comparison and the continent by continent comparison, respectively.
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other European AIMs [24]. It is noteworthy that the
median Fst for the 10 BritAIMs is significantly high within
Europe (P = 0.039), but not within the other continental
groups (Table 2). This observation also supports the
notion that the BritAIMs as a set are at least somewhat
ancestry informative across European populations.
Figure 4 provides a detailed view of the allele frequencies
and population differentiation of the BritAIM that shows
the highest Fst value within Europe, rs7696175. From the
53 × 53 matrix in Figure 4, it can be seen that the high Fst
values for rs7696175 are not restricted to population pair-
wise comparisons within Europe: the French and Orcadi-
ans, for example, have substantially higher minor allele
frequencies than several populations from the Middle East
and Central South Asia. Similar plots are available for the
remaining 9 BritAIMs (Additional File 1) in which it can
be seen that the patterns of population differentiation are
extremely varied across SNPs: many population-pairwise
Fst values lie within the top 5% and even the top 1% of
the empirical distribution. Thus the BritAIMs may be use-
ful as AIMs in other groups of populations, but the pat-
terns are often not systematic and their effectiveness in
other samples would be difficult to predict a priori.
Previous studies have provided some evidence that AIMs
may be portable between human populations. For exam-
ple, microsatellite markers that are ancestry informative in
one population are generally informative in others [45].
Also, genomic regions showing large allele frequency dif-
ferences between one set of continental groups are likely
to be highly-differentiated between other continental
groups [46]. However, more recent studies that focus on
the portability of AIMs across continental groups provide
evidence against this notion. For example, Campbell et al.
[47] previously noted that the use of 67 AIMs that were
discovered to distinguish between African and European
ancestry did not vary sufficiently among Europeans to
allow detection of stratification. Similarly, Paschou et al.
[48] found that SNPs chosen for ancestry inference in one
continent perform no better than random SNPs in infer-
ring ancestry in other continents. These studies have
focused, however, on the portability of AIMs across broad
geographic scales (i.e. between continental groups) and
their conclusions have limited applicability to the design
of association studies which usually focus on a more
refined geographic scale.
Recently, Heath et al. [18] used PCA to assess population
structure in ~6000 Europeans genotyped for ~130,000
SNPs and found that 5 of the 10 genomic regions contain-
ing the BritAIMs examined here were significantly associ-
ated with PC1 or PC2. It is worth noting that the two
BritAIMs for which genotyping failed in the present study
were in regions significantly correlated with PC2, and that
4 of the 5 remaining genomic regions containing BritAIMs
neared significant correlation with PC1 or PC2 [18]. These
data suggest that, while AIMs discovered in a broad panel
of Europeans may not perfectly capture ancestry informa-
tion within Britain, there is substantial overlap among
ancestry-informative genomic regions between the two
geographic scales.
Local, geographically-restricted, natural selection at a
locus generates large allele frequency differences between
populations [49,50]. Thus, AIMs are enriched in genomic
regions that have been targeted by positive selection and
are therefore likely to be in LD with adaptive functional
alleles. Viewed from this evolutionary perspective, our
finding that BritAIMs are not unusually differentiated
between continental groups is not surprising: selection
pressures that have generated allele frequency differences
within Britain are unlikely to be shared across continental
groups because local cultural and physical environments
differ drastically at the continental scale. However, the
BritAIMs' sharp gradients of allele frequencies across Brit-
ain are likely to have been caused by selection pressures
shared by other European populations. For example, one
BritAIM (rs1042712) is found near the lactase gene which
shows a sharp gradient across Europe due to the action of
positive selection for lactose tolerance [51]. Thus, the
portability of AIMs between populations will depend in
part on the extent to which selection pressures have been
shared between the populations. Without extensive popu-
lation genetic analyses, this criterion will be difficult to
evaluate.
Conclusion
The assumption that AIMs are portable across geographic
scales is pervasive [31-34]. The data presented here sug-
gest that there is an inevitable loss of power to detect pop-
ulation stratification when AIMs discovered in one
population are used in another population. Practically,
the assumption that the substructure of the population
under study is adequately similar to the substructure of
the population in which the AIMs were discovered is often
difficult to evaluate. The present analyses suggest the port-
ability of AIMs is limited and that claims of association
between genetic variants and phenotypes should be inter-
preted in accordance with the suitability of the selected
AIMs used to correct for population stratification. As asso-
ciation analyses become increasingly common in popula-
tions for which genome-wide genotype data is sparse, we
anticipate that this cautionary note will become increas-
ingly important.
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